News

Visiting Angels Boosts Dementia Care with Enhanced Training

Visiting Angels Boosts Dementia Care with Enhanced Training

Empowering Care Through Specialized Training

Today we're digging into a move that could reshape how dementia care is delivered right at home. Visiting Angels, a staple in non-medical senior care, is cranking up the expertise with a specialized training program for their franchise owners and staff. We're talking about a full-fledged push for Certified Dementia Practitioner credentials across their sprawling network. You might not see stock tickers flying off the info boards for this, but in the realm where quality care matters, this is a big deal.

A Meaningful Leap Towards Quality Home Care

In June, during their annual conference, Visiting Angels packed 39 of their folks—including franchise owners and key team members—into a room for a deep dive into dementia care. Led by Tim Lindsey, the Executive Director of Operations with the credentials to back his clout (think MS, CDP, CADDCT), this seminar was no joke. It laid the groundwork for these participants to snag a coveted title in the care community: Certified Dementia Practitioner. And why should this get your attention? Anyone who's been around family care knows the value of having trained experts who understand the intricacies of dementia.

The stats aren’t pretty. We’ve got around 7 million Americans aged 65 and older living with Alzheimer's in 2026, and most of them are being cared for at home. The Alzheimer's Association didn’t just toss these numbers around for fun; families are carrying the burden, with professionals like those from Visiting Angels stepping in as the lifeline to make home care manageable.

Bridging Gaps with Knowledge

So, what’s really happening here? It’s about equipping these caregivers with more than just a pat on the back and some good luck wishes. Scott Parrish, President of Visiting Angels, makes no bones about it. Their franchise owners deal with the real, gritty aspects of dementia care. They're not just adding fancy credentials next to their names; they’re learning practical strategies to bring back to their communities. This is a standard of care that Parrish is passionate about—families deserve it, and frankly, it's good business sense to raise the bar.

The Impact of Certification on Care

Participating in training doesn’t mean these folks have arrived. It carves the path for further learning and reassures families that their loved ones are under watchful, knowledgeable eyes. After completing the seminar, these participants are eligible to apply for certification through the National Council of Certified Dementia Practitioners (NCCDP). This credential isn’t a one-and-done deal, either. Oh no, it expects professionals to commit to ongoing education, with recertification every two years. It's a promise of continual growth and adaptation to new care standards.

"We choose to deepen our expertise," said Tim Lindsey, as he underscored their mission to help individuals live confidently while supporting their families. This isn’t just service; it’s dignity through specialized care.

Why Investors Should Take Note

Let’s not glaze over the business side, though. Even if Visiting Angels isn’t ticker-popular, they exist in a space that’s ripe for impact. As the senior population grows, demand for specialized home care constantly nudges upwards, and companies that prepare their workforce for this demand are planting seeds for stability and growth. It's a strategic investment in human capital, and that’s the kind of foresight you don’t ignore.

Taking it all in, we see a market on the move—not just in flashy tech or explosive IPOs, but in the steadfast, critical services that keep families hopeful. Visiting Angels is playing the long game, reinforcing their network with skills and knowledge that speak directly to the needs of our aging population. It’s a move rooted in reality, one that may not skyrocket your portfolio overnight but underscores a sector steadily building its relevance.

Visiting Angels’ commitment to enhancing their service through dedicated training efforts signals a robust response to the ongoing challenges in dementia care, a clear value proposition in today’s shifting healthcare landscape.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 166

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 98

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 218

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 270

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 213

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 171

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 106

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 48

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 0

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading

Top 5 Most Recently Viewed Articles

Cyber Policy Awards Celebrate Leaders in Cybersecurity Innovation

Updated Category News Views 193

The Second Annual Cyber Policy Awards Ceremony The Institute for Security and Technology recently hosted its second annual Cyber Policy Awards, proudly sponsored by Microsoft. This engaging event brought together leaders from various sectors to celebrate remarkable contributions to the field of cybersecurity policy. Honoring Visionaries in Cybersecurity This year, the...

Continue Reading
Bitcoin ETFs Experience Massive Inflows Driving Market Growth

Updated Category News Views 81

Continuous Growth in Digital Asset Inflows Recent reports indicate that digital asset investment products saw significant inflows amounting to $2.7 billion over the past week. This marks an impressive continuation of a positive trend spanning 11 weeks. Overall inflows in the market for the first half of the year have now reached a remarkable $17.8 billion. This persistent...

Continue Reading
NextCure Advances Cancer Treatment with Innovative Approaches

Updated Category News Views 97

NextCure's Promising Advances in Cancer Treatment NextCure, Inc. (NASDAQ: NXTC), a clinical-stage biopharmaceutical company, is making strides in the fight against cancer. Their recent preclinical findings for LNCB74, an innovative antibody-drug conjugate, indicate significant potential for treating various solid tumors. Moreover, the company has provided updates on...

Continue Reading
WEBTOON Entertainment Inc. Faces Class Action Lawsuit for Investors

Updated Category News Views 36

WEBTOON Entertainment Inc. Investor Overview WEBTOON Entertainment Inc. (NASDAQ: WBTN) is a cutting-edge storytelling platform that captivates audiences with its diverse content across multiple genres. Recently, the company has garnered attention due to potential investor losses stemming from its initial public offering (IPO). Robbins Geller Rudman & Dowd LLP has stepped...

Continue Reading
Moxy Chelsea Earns 2024 Readers' Choice Award as Top Hotel

Updated Category News Views 191

Moxy Chelsea Earns Coveted Recognition Moxy Chelsea has once again captured the attention of the hospitality industry by being named one of the top hotels in New York City according to the annual Readers' Choice Awards by Condé Nast Traveler. This prestigious accolade represents the fourth consecutive year Moxy Chelsea has been celebrated in such a manner, showcasing its...

Continue Reading